Full Description
Key features include the provision of new criteria for the diagnosis of symptomatic multiple myeloma requiring treatment and the description of novel therapies for myeloma and other plasma cell neoplasms that have only very recently been licensed by the U.S. Food and Drug Administration.
-
- 洋書電子書籍
- Eat Your Words
-
- 洋書電子書籍
- Labour Problems of …



